Studying at the University of Verona

Here you can find information on the organisational aspects of the Programme, lecture timetables, learning activities and useful contact details for your time at the University, from enrolment to graduation.

Study Plan

This information is intended exclusively for students already enrolled in this course.
If you are a new student interested in enrolling, you can find information about the course of study on the course page:

Combined Bachelor's + Master's degree in Pharmacy - Enrollment from 2026/2027

The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.

2° Year  activated in the A.Y. 2024/2025

ModulesCreditsTAFSSD
3
F
INF/01
English B2
6
E
-

5° Year  It will be activated in the A.Y. 2027/2028

ModulesCreditsTAFSSD
Final exam
18
E
-
activated in the A.Y. 2024/2025
ModulesCreditsTAFSSD
3
F
INF/01
English B2
6
E
-
It will be activated in the A.Y. 2027/2028
ModulesCreditsTAFSSD
Final exam
18
E
-
Modules Credits TAF SSD
Between the years: 1°- 2°- 3°- 4°- 5°

Legend | Type of training activity (TTA)

TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.




S Placements in companies, public or private institutions and professional associations

Teaching code

4S011741

Teacher

Not yet assigned

Credits

9

Language

Italian

Scientific Disciplinary Sector (SSD)

CHIM/08 - PHARMACEUTICAL CHEMISTRY

Period

Secondo semestre 2026/2027 dal Feb 15, 2027 al May 31, 2027.

Courses Single

Not Authorized

Learning objectives

At the end of the course the student will have:
• knowledge of specific classes of drugs affecting the central and peripheral nervous system, pain and inflammation, the hormonal system (in particular steroids, thyroid hormones and calcium homeostasis). For each class of drugs, knowledge of: chemical-physical properties, structure-activity relationships (SAR), development and optimization, mechanisms of interaction with the biological target, biotransformation, and toxic effects is required.
• Understanding of the mechanisms of action at the molecular level.
• Ability to identify pharmacophoric structures and to relate the chemical-physical characteristics to the pharmacological and possibly toxicological effect.
• Ability to identify the application of drugs in the related pathologies, based on the identification of pharmacophore structures

Learning assessment procedures

The exam consists of a written test that will cover the entire program developed in class.
The test lasts 120 minutes and is divided into open-ended questions (relating to specific classes of drugs included in the program, about 30% of the test) and multiple choice questions (about 70% of the test). At the request of the student, and only if the written test has been passed (evaluation ≥18/30) it is possible to integrate the written test with an oral test lasting 20 – 30 minutes.

Students with disabilities or specific learning disorders (SLD), who intend to request the adaptation of the exam, must follow the instructions given HERE

Evaluation criteria

The exam will evaluate the correctness of the proposed solutions, the ability of critical reasoning, the quality of the presentation and the competence in the use of specialized vocabulary.
Mark out of thirty: oral (optional from 3/30 to +3/30.